Guidance for programmatic management of latent tuberculosis infection in the European Union/European Economic Area

Senia Rosales-Klintz¹, Judith Bruchfeld^{2

3}, Walter Haas⁴, Einar Heldal⁵, Rein M G J Houben^{6

7}, Femke van Kessel⁸, Mike Mandelbaum⁹, Alberto Matteelli¹⁰, Giovanni Battista Migliori¹¹, Anouk Oordt-Speets⁸, Ivan Solovic¹², Martina Vašáková¹³, Suzanne Verver¹⁴, Sake J de Vlas¹⁴, Marije J M Vonk Noordegraaf-Schouten⁸, Gerard de Vries^{15

16}, Dominik Zenner¹⁷, Marieke J van der Werf¹

Affiliations

¹ European Centre for Disease Prevention and Control, Stockholm, Sweden.
² Dept of Infectious Diseases, Karolinska Institute, Stockholm, Sweden.
³ Division of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
⁴ Dept of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
⁵ Norwegian Institute of Public Health, Oslo, Norway.
⁶ TB Modelling Group, TB Centre, London School of Hygiene and Tropical Medicine, London, UK.
⁷ Dept of Infectious Disease Epidemiology, London School of Hygiene, London, UK.
⁸ Pallas Health Research and Consultancy, Rotterdam, The Netherlands.
⁹ TB Alert, Brighton, UK.
¹⁰ University Dept of Infectious and Tropical Diseases, and WHO Collaborating Centre for TB/HIV Collaborative Activities and for the TB Elimination Strategy, University of Brescia, Brescia, Italy.
¹¹ Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy.
¹² National Institute for TB, Lung Disease and Thoracic Surgery, Vysne Hagy, Catholic University Ruzomberok, Ruzomberok, Slovakia.
¹³ Dept of Respiratory Medicine, 1st Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czech Republic.
¹⁴ Dept of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
¹⁵ KNCV Tuberculosis Foundation, The Hague, The Netherlands.
¹⁶ National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
¹⁷ Public Health England, London, UK.

PMID: 30655449
DOI: 10.1183/13993003.02077-2018

Editorial

Guidance for programmatic management of latent tuberculosis infection in the European Union/European Economic Area

Senia Rosales-Klintz et al. Eur Respir J. 2019.

. 2019 Jan 17;53(1):1802077.

doi: 10.1183/13993003.02077-2018. Print 2019 Jan.

Authors

Affiliations

¹ European Centre for Disease Prevention and Control, Stockholm, Sweden.
² Dept of Infectious Diseases, Karolinska Institute, Stockholm, Sweden.
³ Division of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
⁴ Dept of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
⁵ Norwegian Institute of Public Health, Oslo, Norway.
⁶ TB Modelling Group, TB Centre, London School of Hygiene and Tropical Medicine, London, UK.
⁷ Dept of Infectious Disease Epidemiology, London School of Hygiene, London, UK.
⁸ Pallas Health Research and Consultancy, Rotterdam, The Netherlands.
⁹ TB Alert, Brighton, UK.
¹⁰ University Dept of Infectious and Tropical Diseases, and WHO Collaborating Centre for TB/HIV Collaborative Activities and for the TB Elimination Strategy, University of Brescia, Brescia, Italy.
¹¹ Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy.
¹² National Institute for TB, Lung Disease and Thoracic Surgery, Vysne Hagy, Catholic University Ruzomberok, Ruzomberok, Slovakia.
¹³ Dept of Respiratory Medicine, 1st Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czech Republic.
¹⁴ Dept of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
¹⁵ KNCV Tuberculosis Foundation, The Hague, The Netherlands.
¹⁶ National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
¹⁷ Public Health England, London, UK.

PMID: 30655449
DOI: 10.1183/13993003.02077-2018

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: S. Rosales-Klintz has nothing to disclose. Conflict of interest: J. Bruchfeld has nothing to disclose. Conflict of interest: W. Haas has nothing to disclose. Conflict of interest: E. Heldal has nothing to disclose. Conflict of interest: R.M.G.J. Houben has nothing to disclose. Conflict of interest: F. van Kessel reports receiving grants from the ECDC. Conflict of interest: M. Mandelbaum has nothing to disclose. Conflict of interest: A. Matteelli has nothing to disclose. Conflict of interest: G.B. Migliori has nothing to disclose. Conflict of interest: A. Oordt-Speets reports receiving grants from the ECDC. Conflict of interest: I. Solovic has nothing to disclose. Conflict of interest: M. Vašakova has nothing to disclose. Conflict of interest: S. Verver reports receiving grants from the ECDC. Conflict of interest: S.J. de Vlas reports receiving grants from the ECDC. Conflict of interest: M.J.M. Vonk Noordegraaf-Schouten reports receiving grants from the ECDC. Conflict of interest: G. de Vries has nothing to disclose. Conflict of interest: D. Zenner has nothing to disclose. Conflict of interest: M.J. van der Werf has nothing to disclose.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Guidance for programmatic management of latent tuberculosis infection in the European Union/European Economic Area

Affiliations

Guidance for programmatic management of latent tuberculosis infection in the European Union/European Economic Area

Authors

Affiliations

Conflict of interest statement

Publication types

MeSH terms

Substances